Consolidated EBITDA stood at RON3.4 million, 209% higher, and the net consolidated profit stood at RON2.4 million, 300% higher, the company said in a statement.
IT Genetics is one of the three companies that applied for non-repayable funds via the National Recovery and Resilience Plan (NRRP) to help them with their listing on the Bucharest Stock Exchange.
(English version by Loredana Fratila-Cristescu)